drugset / Trial / NCT00359359

A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

NCT00359359

Phase 1/2 Completed 26 enrolled Bayer
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine whether the study drug ZK 219477 (also known as SH Y03757A) combined with cisplatin, is effective in the treatment of small cell lung cancer in patients who did not receive prior treatment for their lung cancer

Timeline

Start
2006-07
Primary completion
2009-03
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sagopilone Small molecule 12 mg/m2
Background Cisplatin Other / unclassified 75 mg/m2 Intravenous